Kim Robert Young - Insider Non-Derivative Transactions at 4D Molecular Therapeutics, Inc. (FDMT) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 5, 2024, Kim Robert Young's relationship to 4D Molecular Therapeutics, Inc. (FDMT) is Officer (Chief Medical Officer), and currently has 13,595 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other FDMT insiders.
Data Source: SEC.
Kim Robert Young - Insider Non-Derivative Transactions at FDMT
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 6, 2024 | Sell -- (Common Stock) | 552 | 30.05 | 1043 |
| Feb 6, 2024 | Sell -- (Common Stock) | 12000 | 30.05 | 1595 |
| Feb 6, 2024 | Sell -- (Common Stock) | 6000 | 30.05 | 1595 |
| Feb 6, 2024 | M -- (Common Stock) | 6000 | 15.78 | 7595 |
| Feb 6, 2024 | M -- (Common Stock) | 6000 | 8.04 | 7595 |
| Feb 6, 2024 | M -- (Common Stock) | 12000 | 18.66 | 13595 |